Filing Details
- Accession Number:
- 0001209191-20-031880
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-05-22 19:59:04
- Reporting Period:
- 2020-05-20
- Accepted Time:
- 2020-05-22 19:59:04
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
353569 | Quidel Corp | QDEL | In Vitro & In Vivo Diagnostic Substances (2835) | 942573850 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1333458 | Joseph Robert Bujarski | 9975 Summers Ridge Road San Diego CA 92121 | Svp, Na Comm Ops & Gen Counsel | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2020-05-20 | 20,000 | $189.41 | 13,383 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- The weighted average sale price for these transactions was $189.4141 per share, with a range of $185.705 to $191.62. Upon request, the Reporting Person hereby undertakes to provide to staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder, the full information regarding the number of shares sold at each separate price.